The global dental biomaterials market size was estimated at USD 1,062.5 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. Dental biomaterials include biocompatible synthetic materials and natural tissues that are used to treat tooth decay, damage, and fracture problems. Different types of biocompatible synthetic dental materials are available such as metals, polymers, ceramics, and composite structures. However, natural tissues include enamel, cementum, dentin, bone, and other intraoral tissues. Dental biomaterials are not only used to replace the damaged tooth tissues but to also prevent tissue regeneration. In recent years, tremendous research and improvement has been done in terms of the biomaterials which are used by various dental professionals for dental treatment.
As a result of which various biomaterials have been introduced, that can accelerate biological processes to regenerate the loss of dental tissues. For example, hydroxyapatite is a mineral that is composed of calcium and phosphate ions. Dentists have now incorporated hydroxyapatite (HA) nanoparticles into dental cements and filling materials. This hydroxyapatite helps regenerate the loss of dental tissues.
Major factors responsible for the growth of the market are increasing penetration of dental implants, rising prevalence of tooth disorders, and increasing geriatric population. Moreover, increasing dental tourism and rising disposable income in developing countries will help boost industry growth during the forecast period. Apart from this, recent regulatory changes in the U.S. relating to dental biomaterials are also anticipated to increase the demand for dental biomaterial treatment, thus contributing to the regional market growth.
Increased penetration of dental implants, and incidences of dental disorders due to the high geriatric population is fueling market demand. The rising awareness amongst people about their oral health, coupled with the increased oral health expenditure by clinics, have created a favorable impact on the market growth. The major applications of dental biomaterials are to treat or replace damaged tooth tissues and prevent tissue regeneration.
Furthermore, the rise in medical tourism, wherein patients travel across different regions opt for the treatment of their dental disorders is driving market growth. Extensive research activities on biomaterials is contributing to the improvement in dental treatment.
Increasing investments in the advancement of healthcare infrastructure, for different health problems, is a major growth opportunity for the market. The dependence of the manufacturing companies on the use of metals, and other materials for producing dental products for the treatment, is an opportunity for the industry.
The high cost of procedures for providing dental treatment to patients and strict regulations from the government are the factors restraining the growth of this industry. Furthermore, the lack of availability of trained professionals and skilled medical staff across many regions is hindering industry adoption.
Based on application the orthodontics segment accounted for the largest market share of 42.67% in 2019. The large share of this segment can be attributed due to the rising cases of tooth disorders, growing dental tourism, and increasing disposable income in developing countries. Implants are gaining popularity among patients and are considered as the first option for dental treatment.
Dental laboratories accounted for the largest market share of 42.8% in 2019. The largest share of this segment can be attributed to the increasing number of dental practice, rising prevalence of tooth disorder, and increasing awareness regarding oral hygiene. The dental academies and research institutes segment is anticipated to witness the highest CAGR in the market over the forecast period.
In terms of revenue, the ceramic biomaterials type segment dominated the market with a share of 36.18% in 2019. The large share of this segment can be attributed to the rising penetration of dental implants and the increasing use of ceramic biomaterial in dentistry. The metallic biomaterials provide internal support to the biological tissues and are most widely used in dental implants. Other segments include metallic biomaterials, polymeric biomaterials, natural biomaterials, metal-ceramic biomaterials, and composite biomaterials.
The composite biomaterials segment is anticipated to witness the highest CAGR during the forecast period owing to recent technological development in the composite biomaterials. Also, the segment offers various opportunities to market players due to its low penetration in the market.
North America dominated the market and accounted for a market share of 35.5% in 2019 and is anticipated to continue dominance over the forecast period. This is due to growing government expenditure on oral health, rising aging population, and increasing adoption of dental biomaterials for the production of dental products, and other implants. The rising number of dental hospitals and clinics is also one of the reasons responsible for industry growth in this region.
Asia Pacific is expected to hold a significant industry share over the forecast period due to the increasing incidence of tooth disorder. The region is one of the densely populated areas of the world holding the two most populous countries of the world– India and China, both as emerging global economic leaders. As per the Global Burden of Disease survey in 2018, the Asia Pacific showed a huge burden of oral diseases.
In this region, around 3 to 6.5 out of 10 persons suffer from oral diseases. With increasing durability, the burden of oral disease is bound to increase in the future. In addition, growing medical tourism in emerging economies is also expected to drive market growth in the region. Certain regions, such as the Middle East and Africa and Latin America are projected to exhibit lucrative growth in the near future due to the rapid growth of the industry in these regions.
The key parameter affecting this competitive nature is the rapid adoption of advanced healthcare technology. In addition, major players are often undertaking mergers and acquisitions along with new product launches, to retain industry share and diversify the product portfolio. The major recent developments in this market are enlisted below.
In May 2023, Straumann announced the acquisition of GalvoSurge to provide new innovative solutions to the dental implants with the peri-implantitis cleaning market.The acquisition of GalvoSurge by Straumann is a sign of the growing interest in laser therapy for peri-implantitis.
In November 2021, Geistlich Pharma acquired the medical technology company Meta Technologies S.r.l. to broaden its current offering as a regeneration specialist by adding another prominent brand. With the acquisition, Geistlich Pharma is expanding its existing offering by adding a recognized brand.
Market size value in 2024
USD 1,142.7 milllion
Forecast value in 2030
USD 1,826.5 million
CAGR of 8.1% from 2024 to 2030
2018 - 2023
2024 - 2030
Revenue in USD million and CAGR from 2024 to 2030
Revenue forecast, company share, competitive landscape, growth factors and trends
Type, application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden; China; India; Japan; Australia; South Korea; Malaysia; Indonesia; Singapore; Philippines; Thailand; Mexico; Brazil; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt
Key companies profiled
Straumann Holding AG; Geistlich Pharma AG; Zimmer Biomet Holdings, Inc.; Danaher Corporation; Dentsply Sirona, Inc.; 3M Company; Royal DSM; Carpenter Technology Corporation; Kuraray Co., Ltd.; Medtronic PLC; Henry Schein, Inc.; Mitsui Chemicals, Inc.; Victrex PLC; Ivoclar Vivadent AG; GC Corporation
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2030. For the purpose of this study, Grand View Research has segmented the global dental biomaterials market on the basis of type, application, end-use, and region.
Type Outlook (Revenue, USD Million, 2016 - 2030)
Application Outlook (Revenue, USD Million, 2016 - 2030)
End-use Outlook (Revenue, USD Million, 2016 - 2030)
Dental Hospitals and Clinics
Dental Academies and Research Institutes
Dental Product Manufacturers
Regional Outlook (Revenue, USD Million, 2016 - 2030)
Middle East & Africa
b. The global dental biomaterials market size was estimated at USD 7,716.9 million in 2019 and is expected to reach USD 8,034.0 million in 2020.
b. The global dental biomaterials market is expected to grow at a compound annual growth rate of 6.2% from 2020 to 2027 to reach USD 12,280.2 million by 2027.
b. North America dominated the dental biomaterials market with a share of 35.5% in 2019. This is attributable to rapid innovations in healthcare, and increasing cases of dental caries in the region.
b. Some key players operating in the dental biomaterials market include Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., Medtronic PLC, Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex PLC, Ivoclar Vivadent AG, and GC Corporation.
b. Key factors that are driving the market growth include rising demand for advanced & quality dental products and increasing complexity with respect to product designing & engineering, increasing awareness regarding dental hygiene, and increasing trend of aesthetic dental restoration in young & adult population.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."